Welcome to Recobia Therapeutics, where innovation meets collaboration

Lotfi BOUDALI, MD
CEO and co-founder

Lotfi BOUDALI, MD
CEO and co-founder

Previously Director of the Oncology, Hematology, Nephrology and Transplantation Division at Agence Nationale de Santé du Médicament (ANSM), Lotfi Boudali has a strong expertise in clinical transfer of pharmaceutical drugs.

Alexandre DETAPPE, PhD
CSO and co-founder

Alexandre DETAPPE, PhD
CSO and co-founder

Prof. Detappe leads the nanotranslational laboratory at ICANS, Strasbourg, France. His research focuses on the development of novel nanomedicine platforms applied to medical onco-/hemato-oncology.

Coralie GRANGE, PhD
COO

Coralie GRANGE, PhD
COO

After a PhD on the development of functionalized chitosan-based polymer, Coralie Grange started as COO for Recobia Therapeutics, bringing to the team her knowledge of polymer chemistry.

Xavier PIVOT, MD, PhD
Co-founder

Xavier PIVOT, MD, PhD
Co-founder

Prof. Pivot is the general director of ICANS. He has a strong expertise in the treatment of HER2+ breast cancer and was involved in the clinical trial PrefHer which demonstrated the patient preference for subcutaneous over intravenous formulation of trastuzumab. He was also scientific coordinator and principal investigator of the first Trastuzumab biosimilar registered worldwide.

Olivier TILLEMENT, PhD
Co-founder

Olivier TILLEMENT, PhD
Co-founder

Prof. Tillement is specialized in the development of new therapeutic approaches based on inorganic molecules. This serial entrepreneur is also the co-founder of 6 start-ups and brings its expertise in fund-raising for the success of Recobia Therapeutics.

Vincent GASS
Growth Strategy

Vincent GASS
Growth Strategy

Engineer from Ecole Centrale de Lyon in biotechnologies, Vincent comes with a seasoned experience driving growth as VP marketing and R&D in large chemical specialties organizations, with a recognized expertise in licensing models and business development.